Neurofibromatosis Research Program (NFRP): Exploration-Hypothesis Development Award
US Department of Defense (DoD)
The NFRP was initiated in 1996 to provide support for research of exceptional scientific merit that promotes the understanding, diagnosis, and treatment of Neurofibromatosis (NF) including NF type 1 (NF1) and type 2 (NF2) and Schwannomatosis. Goals are to identify the most effective ways to organize, manage, finance, and deliver high quality care, reduce medical errors, and improve patient safety.
Funding up to a maximum of $100,000 USD in direct costs over two years is available.
Clinic trials are not allowed. Applications must be submitted through eBRAP.
Results Announced: February 2024
Deadlines
| UM Internal Deadline (to ADR) | Sponsor Deadline | |
|---|---|---|
Pre-Application |
| 11-Aug-2023 5:00 pm EST |
Application | 11-Aug-2023 4:30 pm CST | 25-Aug-2023 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.